5 things to know before the stock market opens on Monday

This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox.

Here are five important things investors need to know to start their trading day.

Today’s opening bell marks the start of a new month of trading, and stock futures are rising in pre-market trading. The market is emerging from a triumphant October as momentum in artificial intelligence trading continues to push stock prices higher.

Here’s how things are going at the start of November.

All three major stock indexes rose last month. of S&P500 Although it increased by 2.3% in October, Dow Jones Industrial Average 2.5% increase; Nasdaq Composite In addition to AI trade, signs of easing trade tensions between the U.S. and China also helped boost stocks last month. On Wednesday, President Donald Trump’s tariffs will be scrutinized by the Supreme Court, which will hear oral arguments in a case that could decide the fate of the president’s trade agenda. This week, more than 100 companies will also release their financial results, including: Palantir, Uber, AMD and mcdonalds. For more reports we’re watching, check out The Daily Dividend below. More than 300 companies listed on the S&P 500 have already reported their third quarter results. More than 80% beat Wall Street expectations, according to FactSet. November has historically been the strongest month for the S&P 500, typically up 1.8%, according to the Stock Traders Almanac. Follow us here for live market updates.

Berkshire HathawayThe company reported Saturday that its cash holdings reached a new high of $381.6 billion without repurchases, surpassing the previous record of $347.7 billion set earlier this year. CEO Warren Buffett did not buy back any shares in the Omaha-based conglomerate, even though the company’s stock price has fallen by double digits since May, when Buffett announced his resignation.

Berkshire reported operating income from wholly-owned businesses of $13.485 billion in the third quarter, an increase of 34% from the same period last year. Revenue from Berkshire’s underwriting business increased 200%, boosting the company’s profits. Overall, the company’s profits rose 17% year over year to $30.8 billion.

Investors had mixed feelings about Big Tech’s earnings reports last week, but all members of the Magnificent Seven who reported beat The Street’s earnings estimates for the latest quarter. One particular bright spot is online advertising revenue.

meta, Amazon, alphabet and microsoft All companies reported strong sales in their digital advertising businesses. This is a sign that economic uncertainty has not yet had a negative impact on advertising budgets, as many feared. Big Tech companies’ AI spending also shows no signs of slowing down. Together, the four tech giants expect capital spending (capital investment) to exceed $380 billion this year.

CEO Satya Nadella said in a podcast aired Friday that AI will allow Microsoft to grow its workforce “with greater impact.” Nadella said the number of employees will remain the same in fiscal 2025, but the company will expand its headcount again.

On Friday, a federal judge ruled that the Trump administration must use emergency funds to pay for SNAP food benefits during the ongoing government shutdown. The administration had planned to end the benefits that help feed 42 million Americans on November 1st.

A Rhode Island judge ordered benefits to be paid out of emergency funds “as soon as possible.” Treasury Secretary Scott Bessent told CNN on Sunday that the administration has no intention of appealing the ruling and said it was “possible” to find the money to pay for SNAP by Wednesday.

The lapse in SNAP benefits is just the latest casualty of the shutdown, which is entering its fifth week.

Eli Lilly and novo nordisk At present, the market for weight loss drugs and diabetes drugs can be sustained.

As CNBC’s Annika Kim Constantino reports, new drug companies are vying for a slice of what some analysts estimate could be a $100 billion market by 2030. And facing hurdles to access Eli Lilly’s Mounjaro and Zepbound and Novo Nordisk’s Ozempic and Wegovy, patients continue to turn to cheaper drugs that are imitations of more expensive brand-name drugs.

But two leading drugmakers are hoping to fend off potential competitors. Eli Lilly and Novo Nordisk are both focused on improving supply and convenience, and testing new uses for their drugs, Constantino reported. Novo Nordisk, which trails Eli Lilly in market share, hopes its new CEO will help turn the Danish company around. Analysts believe the company’s products lag behind Eli Lilly’s in terms of safety and effectiveness, and the company’s stock has fallen nearly 40% this year.

Here are the reports and events on our radar this week: Due to the ongoing government shutdown, some economic indicators may not be released as originally scheduled.

Monday: Palantir Technologies Income (after the bell). ISM Manufacturing Index. September Construction Expenditure Data Tuesday: Election Day. Uber Technologies, spotify, Shopify, norwegian cruise line, pfizer and yum brand Income (before the bell). advanced micro device, pinterest, super micro, Hinge health, amgen and Rivian Income (after the bell). International trade data for September. September job openings and turnover survey Wednesday: mcdonalds Income (before the bell). Qualcomm, snap, arm holdings, lift, figma, elf beauty and lucid group Income (after the bell). Weekly mortgage application data. ADP Private Payroll Report. ISM Service Index Thursday: warner bros discovery, tapestry, under armor and moderna Income (before the bell). airbnb, Affirm Holdings, block and peloton interactive Income (after the bell). Weekly unemployment insurance claims. Preliminary third quarter productivity and cost data Friday: October employment report. Preliminary consumer sentiment data

—CNBC’s Fred Imbert, Yun Li, Jonathan Bunyan, Jordan Nove, Dan Mangan, Lisa Kailai Han and Annika Kim Constantino contributed to this report. Terry Cullen edited this version.